New York 11/6/2013 2:21:22 AM
News / Finance

Arrayit Corporation Website Sees 26% Increase in Monthly Traffic

Arrayit Corporation (OTC: ARYC) reports a 26% increase in monthly web traffic to the company’s popular arrayit.com web domain. The Arrayit website received a total of 811,636 web clicks in the month of October compared to 643,309 web clicks in September. Over the past 12 months, Arrayit has recorded 7,390,401 total web clicks and 273,079 unique visitors, consistent with the company’s top product and services rankings on Google, Bing, Yahoo and other leading search engines. 

Arrayit is a leader in microarray technology, empowering scientists and doctors with instruments and consumables to accelerate the human genome discoveries and diagnose human illness on a pre-symptomatic basis for improved prognosis and treatment options. 

Arrayit customers include Google, Illumina, Genentech, and the University of California among many other prestigious biotech, life sciences and pharma accounts. The company recently announced a $1 million capital raise, the addition of renowned Wall Street biotech analyst Sid Taubenfeld to the Board of Directors, and the hiring of John Nesbett and Institutional Marketing Services (IMS) as the company’s investor and media relations experts. ARYC shares are up 447% in the past 90 days on record trading volume. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.

Investor and Media Contact
John Nesbett and Jennifer Belodeau
Institutional Marketing Services (IMS)
203.972.9200
JNesbett@InstitutionalMS.com 
jbelodeau@InstitutionalMS.com